<DOC>
	<DOCNO>NCT02785705</DOCNO>
	<brief_summary>Type 2 component oral poliovirus vaccine slat global withdrawal switch trivalent oral poliovirus vaccine ( tOPV ) bivalent oral poliovirus vaccine ( bOPV ) prevent paralytic polio cause circulate vaccine-derived poliovirus type 2 . We aim assess immunogenicity safety profile six vaccination schedule different sequential dos inactivate poliovirus vaccine ( IPV ) , tOPV , bOPV .</brief_summary>
	<brief_title>Randomized Controlled Trial Immunogenicity Safety Evaluation Bivalent Types 1 3 Oral Poliovirus Vaccine</brief_title>
	<detailed_description>A randomize control trial conduct China 2015 . After informed consent obtain parent legally acceptable representative , healthy newborn baby randomly allocate one six group : cIPV-bOPV-bOPV , cIPV-tOPV-tOPV , cIPV-cIPV-bOPV , cIPV-cIPV-tOPV , cIPV-cIPV-cIPV , tOPV-tOPV-tOPV . The key eligibility criterion : full-term birth ( 37-42 week gestation ) , birthweight ≥2·5 kg , obvious medical disorder polio vaccination . Infants receive follow three dos sequentially 4- 6 week interval collect blood sample : cIPV-bOPV-bOPV , cIPV-tOPV-tOPV , cIPV-cIPV-bOPV , cIPV-cIPV-tOPV , cIPV-cIPV-cIPV , tOPV-tOPV-tOPV ; proactively follow observing adverse event first dose 30 day dos . Antibodies type 1 , 2 , 3 poliovirus test 30 day third dose . The primary study objective investigate immunogenicity safety profile different vaccine schedule , evaluate seroconversion , seroprotection antibody titre poliovirus type 1 , 2 , 3 per-protocol population .</detailed_description>
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Eligible participant healthy fullterm ( 3742 week ) infant age 6090 day weigh 2·5 kg birth obvious medical disorder , polio vaccination , immunoglobulin vaccinate , attenuate vaccine immure past 14 day inactivate vaccine immure . Participants exclude meet one follow criterion : risk immunodeficiency , severe allergic reaction , acute fever infectious disease , severe chronic disease , family history allergy , convulsion , seizure , encephalopathy psychiatric disease , oral steroid least 14 consecutive day past month , axillary temperature equal great 38·0°C past three day , diarrhea ( defection frequency equal great three time per day ) past seven day , participate drug clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>60 Days</minimum_age>
	<maximum_age>90 Days</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>immunization</keyword>
	<keyword>vaccine schedule</keyword>
	<keyword>poliomyelitis</keyword>
	<keyword>polio</keyword>
	<keyword>oral polio vaccine</keyword>
	<keyword>inactivate polio vaccine</keyword>
</DOC>